WELL Health Technologies (TSE:WELL) PT Set at C$5.50 by Royal Bank of Canada

WELL Health Technologies (TSE:WELLGet Free Report) has been given a C$5.50 price objective by investment analysts at Royal Bank of Canada in a research note issued to investors on Tuesday, BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 39.24% from the stock’s previous close.

WELL has been the subject of a number of other reports. TD Securities reduced their price target on shares of WELL Health Technologies from C$8.50 to C$8.00 and set a “buy” rating for the company in a research report on Wednesday, November 15th. Laurentian decreased their target price on WELL Health Technologies from C$9.00 to C$6.50 and set a “buy” rating on the stock in a research note on Thursday, November 16th. Pi Financial lifted their price target on WELL Health Technologies from C$8.25 to C$8.50 in a research report on Wednesday, January 31st. Stifel Nicolaus decreased their price objective on shares of WELL Health Technologies from C$12.00 to C$11.00 and set a “buy” rating on the stock in a research report on Wednesday, November 15th. Finally, CIBC lowered shares of WELL Health Technologies from an “outperform” rating to a “neutral” rating and dropped their target price for the company from C$5.50 to C$4.75 in a research report on Monday, January 22nd. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, WELL Health Technologies presently has an average rating of “Moderate Buy” and an average price target of C$7.30.

Check Out Our Latest Analysis on WELL Health Technologies

WELL Health Technologies Price Performance

WELL stock opened at C$3.95 on Tuesday. The firm has a 50 day moving average of C$3.87 and a 200-day moving average of C$4.10. The firm has a market capitalization of C$948.47 million, a P/E ratio of -197.50, a price-to-earnings-growth ratio of -1.93 and a beta of 1.17. WELL Health Technologies has a 12 month low of C$3.58 and a 12 month high of C$5.94. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 49.27.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers omni-channel healthcare services, including primary care and allied health clinic operations; gastrointestinal, and mental disorders; specialized care, including gastroenterology anesthesia services; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.

Recommended Stories

Analyst Recommendations for WELL Health Technologies (TSE:WELL)

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.